cytarabine has been researched along with 3,4,5-trihydroxybenzamidoxime in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Findenig, G; Fritzer, M; Lhotka, C; Schön, HJ; Szekeres, T | 1 |
| Elford, HL; Fritzer-Szekeres, M; Grusch, M; Höchtl, T; Horvath, Z; Jäger, W; Krupitza, G; Salamon, A; Steinbrugger, R; Szekeres, T | 1 |
3 other study(ies) available for cytarabine and 3,4,5-trihydroxybenzamidoxime
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
[Synergistic cytotoxic effects of chemotherapy in colon tumor cells by simultaneous inhibition of de novo and salvage energy metabolism pathways].
Topics: Allopurinol; Antimetabolites, Antineoplastic; Benzamidines; Cell Line; Cell Survival; Colonic Neoplasms; Cytarabine; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Gemcitabine; Humans; Hypoxanthine; Hypoxanthines; Ribavirin; Ribonucleotide Reductases; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1994 |
Trimidox, an inhibitor of ribonucleotide reductase, synergistically enhances the inhibition of colony formation by Ara-C in HL-60 human promyelocytic leukemia cells.
Topics: Apoptosis; Arabinofuranosylcytosine Triphosphate; Benzamidines; Cell Division; Cytarabine; DNA; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Nucleic Acid Synthesis Inhibitors; Ribonucleotide Reductases | 2002 |